Mary Mihalovic

Bevacizumab Improves Overall Survival in Patients with Advanced Cervical Cancer

04/22/2014

The addition of bevacizumab to the chemotherapeutic regimens of cisplatin-paclitaxel or topotecan-paclitaxel resulted in improved overall survival among patients with advanced cervical cancer, according to results of a recent study [N Engl J...

The addition of bevacizumab to...

04/22/2014

First Report Managed Care

Conference Insider

Comorbidities of Psoriatic Disease

09/24/2015

Mary Mihalovic ;

Psoriatic disease is now understood to be a systemic condition with a link to cardiometabolic risk as well as other comorbidities, including some types of cancers.

Psoriatic disease is now...

09/24/2015

First Report Managed Care

JAK Inhibitor Shows Improvement in Moderate-to-Severe Ulcerative Colitis

12/17/2012

Mary Mihalovic ;

Patients with active ulcerative colitis and treated with the selective oral Janus kinase inhibitor tofacitinib were more likely to show clinical response and remission.

Patients with active ulcerative...

12/17/2012

First Report Managed Care

News Connection

Response to Etanercept in Juvenile Idiopathic Arthritis

01/24/2012

Mary Mihalovic ;

After 15 months of therapy with etanercept, a tumor necrosis factor alpha antagonist, patients with juvenile idiopathic arthritis (JIA) who had had low baseline disability scores, prior disease-modifying antirheumatic drug (DMARD) use, and...

After 15 months of therapy with...

01/24/2012

First Report Managed Care

Requests for Prehospital Emergency Medical Services Increases

12/15/2014

Mary Mihalovic ;

A 40% increase in requests for prehospital emergency medical services was observed over a 10-year period, according to a recent study.

A 40% increase in requests for...

12/15/2014

First Report Managed Care

Increasing Age Predicts Breast Cancer Mortality in Certain Women

04/23/2012

Mary Mihalovic ;

A woman’s risk of dying as a direct result of breast cancer increases with age, according to results of a recent study of postmenopausal women with hormone receptor positive disease [JAMA. 2012;307(6):590-597]. This risk increased regardless...

A woman’s risk of dying as a...

04/23/2012

First Report Managed Care

Dolutegravir a Promising Treatment Option for HIV

03/18/2014

Mary Mihalovic ;

Dolutegravir, used with abacavir and lamivudine, showed more efficacy and a better safety profile in the treatment of HIV-1 infection compared with EFV-TDF-FTC.

Dolutegravir, used with abacavir...

03/18/2014

First Report Managed Care

Conference Insider

Translating Trial Results Into Real-World Practice in IMIDs

09/24/2015

Mary Mihalovic ;

How do findings from clinical trials differ from actual clinical practice in the treatment of immune-mediated inflammatory diseases (IMIDs)? And what are the implications? Three experts answered those questions during a presentation from IAS.

How do findings from clinical...

09/24/2015

First Report Managed Care

Inhaled Corticosteroids Overprescribed for COPD

11/27/2012

Mary Mihalovic ;

Cincinnati—A large percentage of patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) are being prescribed maintenance therapy with inhaled corticosteroids (ICS), a practice that is not consistent with the Global...

Cincinnati—A large percentage of...

11/27/2012

First Report Managed Care

News Connection

Platelet Inhibition to Bridge Patients for CABG

03/16/2012

Mary Mihalovic ;

The use of cangrelor, an intravenous antagonist of the P2Y12 receptor, to bridge patients after they discontinue antiplatelet therapy in preparation for coronary artery bypass graft (CABG) surgery, was shown to effectively provide platelet...

The use of cangrelor, an...

03/16/2012

First Report Managed Care